Case report
A 47-year-old man presented to our institution with a five-day history of abdominal pain and vomiting. His past medical history included mild asthma, treated with inhaled salbutamol, and hypertension, not requiring drug treatment. He had an alcohol intake of 90 units per week, and smoked 20 cigarettes per day.
Initial investigations revealed a raised serum amylase (332 units/L), a neutrophilia (14.8×10 9 /L), and a low serum adjusted calcium (1.88 mmol/L). Both serum triglycerides (42.4 mmol/L) and serum cholesterol (11.8 mmol/L) were markedly elevated. Arterial blood gases revealed mild hypoxaemia (PaO 2 7.9 kPa on air), with a metabolic acidosis: base excess 5.2 mmol/L and serum lactate 3.9 mmol/L. Abdominal computed tomography (CT) demonstrated peripancreatic mesenteric stranding and multiple fluid collections in the upper abdomen, but with no evidence of pancreatic necrosis (ie a CT Severity Index score of 4) or gallstones.
A diagnosis of acute severe pancreatitis was made. Identifying the aetiology of pancreatitis in this case was not straightforward; it may have been due to an acute alcohol binge (something the patient strenuously denied) on the background of chronic excess, due to chronic alcohol-induced hypertriglyceridaemia, or 'pure' hypertriglyceridaemia of genetic origin. Given the extraordinarily high presenting plasma triglyceride concentration (42.4 mmol/L), we felt that primary or secondary hypertriglyceridaemia was the most likely aetiology of pancreatitis. Procrastination over the aetiology of pancreatitis is not just academic; hypertriglyceridaemia-induced pancreatitis differs from pancreatitis of other aetiology in the management of nutritional support, with fasting (see discussion) and enteral nutrition 1 being accepted practice respectively.
The patient was duly fasted, and his stomach decompressed with a nasogastric tube. Given the level of hyper-triglyceridaemia, it was decided to undertake plasmapheresis. However, its commencement was delayed due to both clinical (the development of acute respiratory distress syndrome) and non-clinical problems (admission occurring on a bank holiday weekend, with dialysis facilities located at a different site to the intensive care unit (ICU)). On day 3, an insulin sliding scale was started when the serum glucose rose above 11.0 mmol/L. By day 3, serum triglycerides had fallen to 5.9 mmol/L and serum cholesterol to 3.5 mmol/L without plasmapheresis therapy. Later that day, enteral feeding was commenced.
On day 20, the patient had been commenced on a fibrate and was discharged to the general ward with serum triglycerides of 1.0 mmol/L and serum cholesterol of 1.8 mmol/L. Repeat CT scan demonstrated distal pancreatic necrosis and pseudocyst formation, which required drainage. The patient was discharged from hospital four weeks later. He was reviewed as an outpatient at two months, but declined further testing for hypertriglyceridaemia and subsequently failed to attend appointments. Serum triglycerides remained in the normal range at six months.
Discussion
Hypertriglyceridaemia is well-documented to be associated with acute pancreatitis, and is the third most common precipitant after alcohol and gallstones, 2 comprising 5-10% of pancreatitis episodes. 2, 3 In addition, up to 50% of patients with acute pancreatitis of another aetiology develop mildly or moderately elevated serum triglycerides. 4 Although controlled studies have not been done, 5 serum triglycerides greater than 11.3 mmol/L (1,000 mg/dL) are referred to as 'severe,' and are said to be associated with a greater risk of acute pancreatitis. 2
Overview of lipid metabolism
Lipoproteins are biochemical assemblies containing both protein and lipid. There are five classes of lipoprotein, which
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can be separated by ultracentrifugation and classified on the basis of their density: chylomicrons, very-low-density lipoprotein (VLDL), intermediate-density lipoprotein, lowdensity lipoprotein and high-density lipoprotein. Circulating triglyceride originates from two sources: exogenous (dietary) triglyceride is carried from the intestines by chylomicrons, while endogenous triglyceride is carried from the liver by VLDL.
Chylomicrons are relatively large molecules (75-400 nm diameter) synthesised exclusively by small intestine enterocytes and are predominantly composed of triglycerides (85%). The chylomicrons are then secreted into lacteals, and ultimately enter the venous circulation via the thoracic duct where they carry triglycerides to the liver, adipose tissue, heart and skeletal muscle. They are usually only identified in the circulation in the hours following a lipid-rich meal.
Once in the circulation, chylomicrons acquire the surface protein apolipoprotein C-II (APOC2), a cofactor for lipoprotein lipase (LPL). LPL is an insulin-sensitive water-soluble lipase attached to the luminal surface of endothelial cells, predominantly expressed in adipose tissue, heart and skeletal muscle capillary beds. The interaction between LPL and APOC2 allows dietary triglyceride to be offloaded from the circulating chylomicrons to the peripheral tissues, generating chylomicron remnants. VLDL also displays the APOC2 surface protein; LPL facilitates the peripheral offloading of VLDL triglyceride.
Causes of hypertriglyceridaemia
Hypertriglyceridaemia occurs following ingestion of excessive exogenous triglyceride, synthesis of excessive endogenous triglyceride, or ineffective triglyceride clearance.
Hypertriglyceridaemia may be classified as primary (due to a genetic disorder) or secondary. Of the primary familial hyperlipidaemias, types I, IV and V are associated with pancreatitis: • Type I hyperlipidaemia (familial chylomicronaemia) classically presents in childhood with a triad of eruptive xanthomata, lipaemia retinalis and pancreatitis. It is an autosomal recessive condition resulting from either LPL deficiency or APOC2 deficiency, which both result in impaired chylomicron clearance. • The causes of types IV and V hyperlipidaemia are less clear.
Patients present in adulthood with elevated triglyceride and VLDL levels (type IV), or chylomicrons and VLDL levels (type V). Common secondary causes of hypertriglyceridaemia include poorly controlled diabetes mellitus, alcohol consumption, pregnancy, hypothyroidism and drugs: • Type I diabetes mellitus is associated with significantly reduced activity of the insulin-sensitive enzyme LPL, which reduces plasma triglyceride clearance. Patients with type II diabetes and obesity also have reduced LPL activity, 6 though the mechanism for this is unclear. • Acute alcohol consumption has been shown to increase plasma triglycerides through two mechanisms: acute inhibition of LPL, and increased hepatic synthesis of VLDL. 7 It has been said that alcohol alone does not increase serum triglycerides sufficiently to trigger acute pancreatitis; a coexisting primary or secondary cause of hyperlipidaemia is required. 2 However, a recent study has shown chronic alcohol excess to be the only risk factor for raised triglycerides in a subgroup of patients with known hypertriglyceridaemia. 8 Many of these patients had significantly elevated triglyceride levels (>26.8 mmol/L). In our case, given that serum triglycerides fell to the normal range (albeit following fibrate therapy), it is possible that chronic alcohol consumption in conjunction with a genetic tendency towards hypertriglyceridaemia was responsible for the very high levels of serum triglycerides at presentation. • Triglycerides increase 2-4 fold in pregnancy, both due to a decrease in LPL activity due to insulin resistance, and oestrogen-induced hepatic VLDL synthesis. 9 Up to 56% of gestational pancreatitis is reported to be linked to hypertriglyceridaemia. 10 Hypertriglyceridaemia is a finding in 35% of hypothyroid patients, 11 again due to impaired LPL activity.
Pharmaceutical agents causing secondary hypertriglyceridaemia include oestrogens, glucocorticoids and thiazide diuretics. 12
Triglyceride-induced acute pancreatitis
The pathophysiology of triglyceride-induced acute pancreatitis remains speculative. Chylomicrons have been implicated in pancreatic inflammation. Hyperchylomicronaemia (which occurs in conjunction with serum triglycerides >10 mmol/L) increases plasma viscosity, which impairs pancreatic capillary blood flow and causes pancreatic ischaemia. A cascade of pancreatic autodigestion and inflammation is thereby triggered. 13 An alternative hypothesis involves the lysis of circulatory triglyceride, with the aggregation of the resulting free fatty acids into micelles. The micelles may cause pancreatic capillary bed damage, triggering the inflammatory cascade. 14 Triglyceride-triggered acute pancreatitis differs little from pancreatitis of other aetiology with regard to clinical presentation, pancreatic necrosis 4 and acute respiratory distress syndrome. 15 However, the severity of pancreatitis and mortality are reported to be higher, 16 with complications such as renal failure more common. 15
Management of triglyceride-induced acute pancreatitis
In common with acute pancreatitis of other aetiology, the management of the pancreatic inflammatory cascade triggered by hypertriglyceridaemia is largely supportive. Although there is no specific evidence available, a logical assumption is that the inflammatory process may be sustained by continued hypertriglyceridaemia. 17 Therefore, specific therapies in triglyceride-induced acute pancreatitis have concentrated on reducing serum triglyceride to below 11.3 mmol/L. However, it is important to note that there is no evidence to suggest that an induced fall in serum triglycerides is associated with either an improvement in the clinical course of pancreatitis, or mortality.
Broadly, triglyceride-lowering strategies employed are conservative (fasting and nasogastric drainage), insulin, heparin and plasmapheresis.
Case reports
• Conservative treatment: Serum triglycerides are reduced by fasting, both by preventing further chylomicron synthesis and by LPL-induced clearance of circulating chylomicrons and VLDL. Despite the fact that the temporal course of acute pancreatitis and its relation to serum triglyceride concentration are not well described in the literature, there is general agreement that fasting causes a rapid fall in serum triglycerides. 4, 18 The serum triglyceride in this case fell by 86% over three days with conservative management alone.
A similarly rapid decline in serum triglycerides has been noted in other case reports. 19, 20 In fact, there is a concern that serum triglycerides may fall so rapidly over the first 72 hours that a delay in presentation may lead to false conclusions over the aetiology of pancreatitis. 4 • Insulin: Insulin therapy has been used in both diabetic and non-diabetic patients with acute pancreatitis, leading to rapid falls in serum triglyceride. 20, 21 However these patients were also fasted, so that how much of the reduced triglyceride concentration can be attributed to insulin is not clear. • Heparin: The use of heparin in triglyceride-induced acute pancreatitis is controversial. Intravenous heparin has long been known to interact with LPL, uncoupling LPL from the endothelium and releasing it into the circulation. 22 However LPL concentration only rises transiently, followed by increased hepatic degradation and depletion of plasma stores, leading to LPL deficiency. 23 There is also concern about exacerbating the risk of haemorrhagic pancreatitis. Despite this, heparin infusions have been successfully used to treat hypertriglyceridaemia in acute pancreatitis in conjunction with fasting, 24 or more commonly with both insulin and fasting. 25 • Plasmapheresis: Plasmapheresis has been shown to significantly reduce serum triglyceride concentration in chronic hypertriglyceridaemia. 26 In triglyceride-induced acute pancreatitis, plasmapheresis is reported to dramatically reduce serum triglycerides and also to reduce the circulating load of pro-inflammatory cytokines. 27 Over the last decade, a number of case reports 17, 28, 29 and small case series [30] [31] [32] [33] [34] have been published regarding the use of plasmapheresis in triglyceride-induced acute pancreatitis. Many of these case reports describe a rapid improvement in pain and clinical features following plasmapheresis, coinciding with a fall in serum triglycerides. In the longer term, patients with hypertriglyceridaemia remain at risk of both further episodes of acute pancreatitis and cardiovascular complications. Formal diagnosis should be secured by measuring fasting serum triglycerides, and secondary causes excluded. Management options include lifestyle and dietary modification, fibrates and statins. 35
Is plasmapheresis indicated in triglycerideinduced acute pancreatitis?
Plasmapheresis has clearly been shown to reduce serum triglyceride concentration in chronic hypertriglyceridaemia. 26 Many of the published reports of acute pancreatitis claim that the observed dramatic fall in serum triglyceride is the result of timely plasmapheresis. As a result, the American Society for Apheresis has promoted plasmapheresis in the management of triglyceride-induced acute pancreatitis with a weak recommendation. 36 Whether plasmapheresis can be credited for the claims made in the case reports is debatable. Firstly, the fall in serum triglycerides quoted following plasmapheresis is 60-90% by day 3-5. 17, [28] [29] [30] [31] [32] [33] [34] Serum triglycerides have been shown to fall equally dramatically following heparin therapy (76% fall at 18 hours), 24 insulin (96% fall at day 5) 21 or fasting (96% at day 3). 19 In addition, in all of the cases using plasmapheresis, patients were also fasted; many of those who reported details also used IV heparin in the extracorporeal circuit. Without a control group, attributing the fall in serum triglyceride to plasmapheresis alone cannot be justified. Indeed, the only case series to use a control group demonstrated no statistical difference in mortality of pancreatitis-associated complications between plasmapheresis and conservative management. 37 Secondly, claims about improved pain and clinical features of pancreatitis following plasmapheresis were made. None of these claims were objectively assessed, and no control groups used. In the clinical experience of the authors, abdominal pain and clinical features of non-triglyceride acute pancreatitis also often show subjective improvement by day three.
Finally, if one accepts that plasmapheresis offers the patient no benefit in terms of lowering of serum triglyceride concentration, the cost of treatment cannot be justified. Though rare, the complications of plasmapheresis may contribute to morbidity or even mortality, 38 especially in the haemodynamically compromised patient. Indeed, one case series expressed concern that the mortality rate of patients with acute pancreatitis who underwent plasmapheresis was 15%, higher than the reported average (9%). 33 
Conclusions
In triglyceride-induced acute pancreatitis, a triglyceridelowering strategy (although not evidence-based) is probably justified; conservative management achieves this desired fall in serum triglyceride concentration. There is insufficient evidence to either recommend or reject plasmapheresis as a strategy for lowering triglycerides in the acute phase of an episode of pancreatitis. Plasmapheresis offers theoretical benefit through a reduction in circulating pro-inflammatory cytokines, but this is yet to be proved. Good quality controlled trials are required to guide future management. In the meantime, clinicians should be mindful of the cost and potential complications of such a strategy, which should arguably be reserved for patients in whom triglycerides remain elevated by day 3 despite fasting.
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